-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Neutral on Minerva Neurosciences, Lowers Price Target to $4

Benzinga·11/06/2025 11:58:08
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the price target from $5 to $4.